Mekinist Tablet, Film Coated
Product Images NDC 0078-1105

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Mekinist (NDC 0078-1105). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novartis Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Trametinib Structure-01 (Mekinist 01)

Chemical structure diagram of trametinib, the active ingredient in Mekinist tablets. The diagram shows the molecular structure including rings, atoms, and bonds characteristic of trametinib's chemical composition.*

FDA Label Image

Figure 1. Kaplan-meier Curves Of Investigator-assessed Progression-free Survival (itt Population) In The Metric Study (Mekinist 02)

A Kaplan-Meier plot showing proportion progression-free over months for Mekinist (trametinib) versus chemotherapy. The graph compares progression-free survival for Mekinist (N=214) with chemotherapy (N=108), including median months progression-free, hazard ratio, and confidence interval.*

FDA Label Image

Figure 2. Kaplan Meier Curves Of Overall Survival In The Combi-d Study (Mekinist 03)

A Kaplan-Meier survival curve chart comparing the proportion alive over time in months from randomization between two groups: Tafinlar plus Mekinist (N=211) and Tafinlar plus Placebo (N=212). The chart includes median survival times, hazard ratio, confidence interval, and P value, with a table of numbers at risk across time points below the graph.*

FDA Label Image

Mekinist 04

Mekinist (trametinib) Tablets 0.5 mg film-coated oral tablets package label. The label indicates 30 tablets, Rx only, manufactured by GlaxoSmithKline Manufacturing S.p.A., distributed by Novartis Pharmaceuticals Corporation. Storage instructions include refrigeration at 2°C to 8°C (36°F to 46°F) and warnings about seal integrity and moisture protection.*

FDA Label Image

Mekinist 05

Mekinist 2 mg trametinib tablets label by Novartis Pharmaceuticals Corporation. The film-coated oral tablets contain trametinib dimethyl sulfoxide equivalent to 2 mg trametinib. The label shows a 30-tablet count, with storage instructions for refrigeration at 2°C to 8°C, and warnings about safety seal, desiccant, and moisture protection. Manufactured by GlaxoSmithKline Manufacturing in Italy, distributed by Novartis, product of Singapore.*

FDA Label Image

Mekinist 06

A Kaplan-Meier survival curve chart showing the proportion alive and relapse-free over time in months from randomization, comparing TAFINLAR + MEKINIST combination therapy to Placebo. The chart includes a time axis from 0 to 51 months and a vertical axis representing the proportion alive and relapse-free from 0 to 1. Below the graph, the number of subjects at risk at various time points is listed for both treatment groups.*

FDA Label Image

Mekinist 07

Mekinist 0.5 mg film-coated tablets label by Novartis Pharmaceuticals Corporation. The label notes each tablet contains 0.5635 mg trametinib dimethyl sulfoxide, equivalent to 0.5 mg trametinib, with a quantity of 30 tablets. Storage instructions specify refrigeration at 2°C to 8°C (36°F to 46°F) and warnings about the safety seal and protection from moisture and light. The label includes a barcode and NDC 0078-1105-15.*

FDA Label Image

Mekinist 08

Mekinist 2 mg film-coated tablets label showing the active ingredient trametinib. The label includes dosage information, manufacturer details (Novartis Pharmaceuticals Corporation, Stein, Switzerland), and storage instructions requiring refrigeration at 2°C to 8°C. The package size is 30 tablets, and the label features the Novartis logo with NDC 0078-1112-15.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.